Meditation Strategies, Attention, and Mobility in Older Adults

December 4, 2023 updated by: Lindsay Nagamatsu, Western University, Canada
Approximately 30% of community-dwelling older adults experience one or more falls per year, resulting in injuries, loss of independence, and reduced quality of life. While there are known physiological risk factors for falls, including poor balance and altered gait patterns, it is now recognized that impaired cognitive functioning is also a risk factor for falls. Within the broad construct of cognition, one specific domain that has been focused on in the falls literature is attention. The literature suggests that improving attention in those at-risk for falls may reduce older adult's risk of falling.

Study Overview

Detailed Description

The current study aims to investigate the impact of meditation strategies on measures of attention and electrical signals in the brain in older adults. Investigators will recruit older adults who are living in the community. Participants will be assigned to one of two groups: 1) guided focused attention group, or 2) music group (control group). All participants will complete three in-person sessions per week and then be encouraged to practice independently on the other days in the week, for a total of four weeks.The current study focuses on focused attention meditation strategies, as it is recommended for beginner-level meditators. This will include training to be able to focus on one's breathing for 20 minute sessions. Focused attention meditation has been found to increase levels of executive functioning and attention. Participants will complete mobility and cognitive assessments at both the beginning and end of the intervention. These will be completed in the retirement homes for convenience. Participants will also attend an in-lab session to complete electroencephalogram (EEG) testing at both timepoints.

Study Type

Interventional

Enrollment (Actual)

43

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Lindsay S Nagamatsu, PhD
  • Phone Number: 88284 519-661-2111
  • Email: lnagamat@uwo.ca

Study Locations

    • Ontario
      • London, Ontario, Canada
        • Community

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. minimum 60 years of age,
  2. minimum completed high school,
  3. must be comfortable writing and reading English,
  4. be able to walk independently,
  5. must be right-handed (for EEG analysis),
  6. score 6+/8 on the instrumental activities of daily living scale,
  7. score >24/30 on the Mini-Mental Status examination.

Exclusion Criteria:

To be included, participants must NOT:

  1. have a diagnosis of neurodegenerative disease,
  2. have a diagnosis of cognitive impairment (e.g., MCI),
  3. have a diagnosis of a psychiatric condition,
  4. have had a concussion in the last 12 months,
  5. have had a stroke,
  6. have musculoskeletal or joint disease,
  7. experience dizziness or loss of balance,
  8. have visual, auditory, or somatosensory impairment, or
  9. a recent history (past 2 years) of regular meditation practice (1 or more times per week) or include a meditation component in their religious practice.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Guided focused attention

Participants will take part in a guided focused attention practice led by the researcher. This will include strategies used in meditations where participants focus on their breathing. More specifically, they will be instructed to close their eyes and focus on the sensation of breathing in one area of the body for the entire session. They will be given reminders throughout the session to remain on task (focusing on the breath) and not to let their thoughts wander.

Participants will be asked to either sit on a chair or cushion on floor to ensure they are comfortable to sit still for the session, but not so much that they might fall asleep.

Participants will meet for 20 minute group sessions with 6-10 participants in each group. There will be three meetings a week for a four week period. The focused attention practice itself will last for 20 minutes with instructions being given during the 20 minute period. All sessions will occur in the retirement home in a community room to ensure the sessions are easily accessible to the participants.
Active Comparator: Acoustic music

Participants will be instructed to listen to a prepared soothing acoustic music track. The sessions will be led by a researcher. Participants will be asked to close their eyes and relax while listening to the music.

Participants will be asked to sit on a chair or cushion on floor to ensure they are comfortable to sit still for the session, but not so much they might fall asleep This group is used as active control group to control for socialization in group settings and any effects of consciously relaxing for the meetings.

Participants will meet for 20 minute group sessions with 6-10 participants in each group. There will be three meetings a week for a four week period. The acoustic music track itself will last for 20 minutes with instructions being given during the 20 minute period. All sessions will occur in the retirement home in a community room to ensure the sessions are easily accessible to the participants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in sustained attention
Time Frame: 4 weeks
Measured by performance on sustained attention task.
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in global attention
Time Frame: 4 weeks
Measured by electrophysiological measures of attention.
4 weeks
Change in mobility
Time Frame: 4 weeks
Measured by the Timed Up and Go test.
4 weeks
Change in mobility and balance
Time Frame: 4 weeks
Measured by the Short Physical Performance Battery.
4 weeks
Change in memory
Time Frame: 4 weeks
Measured with the Rey Auditory Verbal Learning Test
4 weeks
Change in conflict resolution
Time Frame: 4 weeks
Measured with the stroop task
4 weeks
Change in set-shifting
Time Frame: 4 weeks
Measured with the trail making task
4 weeks
Change in working memory
Time Frame: 4 weeks
Measured with the digit span task
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lindsay S Nagamatsu, PhD, Western University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2019

Primary Completion (Actual)

August 31, 2019

Study Completion (Actual)

August 31, 2019

Study Registration Dates

First Submitted

January 12, 2018

First Submitted That Met QC Criteria

January 23, 2018

First Posted (Actual)

January 31, 2018

Study Record Updates

Last Update Posted (Actual)

December 5, 2023

Last Update Submitted That Met QC Criteria

December 4, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 110598

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobility Limitation

Clinical Trials on Guided focused attention

3
Subscribe